Other HIV PrEP studies at CROI 2015: implementation of oral PrEP and problems with tenofovir gel
24 March 2015. Related: Conference reports, HIV prevention and transmission.
Conference reports
Early HIV treatment and isoniazid prophylaxis: why TEMPRANO results do not yet support universal ART at CD4 counts >500
24 March 2015. Related: Conference reports, Treatment strategies, TB coinfection.
Unintended pregnancies with levonorgestrel implant due to drug interactions with efavirenz-based ART
24 March 2015. Related: Conference reports, Women's health, PK and drug interactions.
Three drug ART best for preventing vertical transmission to infants: results from the PROMISE study
24 March 2015. Related: Conference reports, Pregnancy.
3 in 5 breastfeeding women with viral load >1,000 copies/mL are undiagnosed in Kenya, Malawi and South Africa
24 March 2015. Related: Conference reports, Pregnancy.
Point of care HIV PCR test for infant diagnosis: good performance but poorer results in youngest age group
24 March 2015. Related: Conference reports, Pregnancy, Paediatric care, Diagnostics.
Weekend-off ART is non-inferior to continuous ART in young people taking efavirenz-based regimens: results from BREATHER study
24 March 2015. Related: Conference reports, Treatment strategies, Paediatric care.
Increased cardiovascular risks in HIV positive children in Uganda and Zambia partially reversed by ART
24 March 2015. Related: Conference reports, Paediatric care, Coinfections and complications.
Lopinavir/ritonavir superior to nevirapine in children <3 years old: IMPAACT P1060 five year results
24 March 2015. Related: Conference reports, Paediatric care.
Long-term safety and efficacy of tenofovir in children
24 March 2015. Related: Conference reports, Paediatric care.
UK case of HIV remission: ten years off-ART in patient with prior progression and treated during seroconversion
24 March 2015. Related: Conference reports, Cure-related research.
XXIV International HIV Drug Resistance Workshop , 21-22 February 2015, Seattle, Washington
24 March 2015. Related: Conference reports, Drug resistance.
Prevalence of transmitted drug resistance globally: highest in Australia, US and some European countries but between-country differences in all regions
24 March 2015. Related: Conference reports, Drug resistance.
Higher rates of K65R in non-B subtype in large UK cohort and implications of tenofovir resistance in resource-limited settings
24 March 2015. Related: Conference reports, Drug resistance.
Drug resistance and integrase inhibitors: potential impact of HIV subtype
24 March 2015. Related: Conference reports, Drug resistance.
Drug resistance in children after PMTCT and early treatment
24 March 2015. Related: Conference reports, Pregnancy, Paediatric care, Drug resistance.
Five Nations Conference on HIV and Hepatitis – 8-9 December 2014, London
29 January 2015. Related: Conference reports.
Summary of the pre-conference clinical course
29 January 2015. Related: Conference reports, Hepatitis coinfection.
Hepatitis C drug access: Europe is the new Africa
29 January 2015. Related: Conference reports, Treatment access, Hepatitis coinfection.
45th Union World Conference on Lung Health, 28 October – 1 November 2014, Barcelona, Spain
29 January 2015. Related: Conference reports.
Good outcomes within the National Bedaquiline Clinical Access programme in South Africa
29 January 2015. Related: Conference reports, TB coinfection.
Pharmacokinetics and safety of moxifloxacin in children
29 January 2015. Related: Conference reports, Paediatric care, PK and drug interactions.
TB in the ARROW trial of children on ART
29 January 2015. Related: Conference reports, Paediatric care, TB coinfection.
Problems giving current second line TB drugs to children
29 January 2015. Related: Conference reports, Paediatric care, TB coinfection.
12th Glasgow Congress on HIV Therapy, 2-6 November 2014, Glasgow
1 December 2014. Related: Conference reports.
Savings to the NHS predicted from switching to generic antiretrovirals
1 December 2014. Related: Conference reports, Antiretrovirals, Treatment access.
Lower dose efavirenz effective in two studies
1 December 2014. Related: Conference reports, Antiretrovirals.
Should tenofovir dose be 200 – 250 mg when used with protease inhibitors?
1 December 2014. Related: Conference reports, Antiretrovirals.
3TC inferior to FTC in Dutch cohort but interchangeable in other studies
1 December 2014. Related: Conference reports, Antiretrovirals.
Suicide not associated with efavirenz use in the D:A:D cohort study
1 December 2014. Related: Conference reports, Antiretrovirals, Side effects.
Gender differences in use of cardiovascular disease-related interventions: D:A:D study
1 December 2014. Related: Conference reports, Treatment strategies, Women's health, Side effects.
Efavirenz decreases exposure to hormonal contraceptive implant
1 December 2014. Related: Conference reports, Antiretrovirals, Side effects.
Increased risk of ART-related hepatotoxicity in HIV positive pregnant women
1 December 2014. Related: Conference reports, Antiretrovirals, Pregnancy, Side effects.
Darunavir pharmacokinetics in pregnancy and postpartum
1 December 2014. Related: Conference reports, Antiretrovirals, Pregnancy.
BHIVA Autumn Conference, 9-10 October 2014, London
1 December 2014. Related: Conference reports.
Good management of HIV positive pregnant women in UK – with some room for improvement
1 December 2014. Related: Conference reports, Pregnancy.
Southern African Clinicians Society Conference, 24-27 September 2014, Cape Town, South Africa
1 December 2014. Related: Conference reports.
Efavirenz-associated gynaecomastia reported to the national HIV and TB healthcare workers hotline in South Africa
1 December 2014. Related: Conference reports, Antiretrovirals, Side effects.
Infants start ART too late but improvement over time in Southern Africa
1 December 2014. Related: Conference reports, Antiretrovirals, Paediatric care.
Treatment outcomes in HIV positive and negative people with drug resistant TB in Khayelitsha, Cape Town
1 December 2014. Related: Conference reports, TB coinfection.
Pregnancy a risk factor for poor antiretroviral treatment outcomes in South African adolescents
1 December 2014. Related: Conference reports, Antiretrovirals, Women's health, Pregnancy.
54th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), 5-9 September 2014, Washington, DC
1 October 2014. Related: Conference reports.
Antiretroviral studies at ICAAC 2014: darunavir-based FDC with TAF, cobicistat, doravirine, Stribild and gel formulation PrEP
1 October 2014. Related: Conference reports, Antiretrovirals, HIV prevention and transmission.
Switch from efavirenz to rilpivirine quells CNS toxicity, improves sleep
1 October 2014. Related: Conference reports, Antiretrovirals.
HIV persists in lung macrophages of people on suppressive ART
1 October 2014. Related: Conference reports, Antiretrovirals, Cure-related research.
Only 10% of veterans with HCV or HCV/HIV in the US treated for HCV
1 October 2014. Related: Conference reports, Hepatitis coinfection.
20th International AIDS Conference, 20-25 July 2014, Melbourne
1 October 2014. Related: Conference reports.
Update on baseline STIs in UK oral PrEP study (PROUD)
1 October 2014. Related: Conference reports, HIV prevention and transmission.
High prevalence of COPD at baseline in START study sub-study
1 October 2014. Related: Conference reports, Coinfections and complications.
Risk of CVD or type-2 diabetes according to change in BMI after starting ART
1 October 2014. Related: Conference reports, Antiretrovirals, Side effects.
Rosuvastatin may be partially effective in moderating residual immune activation on ART
1 October 2014. Related: Conference reports, Side effects.
Reasons for loss to follow up in the Malawi Option B+ programme
1 October 2014. Related: Conference reports, Pregnancy.
20th International AIDS Conference, 20-25 July 2014, Melbourne
1 August 2014. Related: Conference reports.
The loss of friends and colleagues from flight MH 17
1 August 2014. Related: Conference reports.
Higher ART coverage is associated with lower HIV infection rates in a multi-country analysis
1 August 2014. Related: Conference reports, Treatment strategies, HIV prevention and transmission.
Pill A, Pill B: simplified second-line treatment for low-income countries
1 August 2014. Related: Conference reports, Antiretrovirals, Treatment access.
UNAIDS sets 90-90-90 target for 2020 to end AIDS by 2030
1 August 2014. Related: Conference reports, Treatment access.
No difference in overall anaemia rate with reduced dose AZT
1 August 2014. Related: Conference reports, Treatment strategies, Treatment access.
Open label oral PrEP at four doses a week: why zero infections does not equal 100% efficacy
1 August 2014. Related: Conference reports, HIV prevention and transmission.
Cure research at IAS 2014: TILDA measures the reservoir and romidepsin wakes it up
1 August 2014. Related: Conference reports, Cure-related research.
HIV and transgender issues at AIDS 2014
1 August 2014. Related: Conference reports.
Transgender services and clinics: interviews at AIDS 2014 with JoAnne Keatley and Beatriz Grinsztejn
1 August 2014. Related: Conference reports, Activism & advocacy.
Publications launched at AIDS 2014
1 August 2014. Related: Conference reports.
6th International Workshop on HIV Paediatrics, 18-19 July 2014, Melbourne
1 August 2014. Related: Conference reports.
Update on paediatric antiretrovirals
1 August 2014. Related: Conference reports, Antiretrovirals, Paediatric care.